Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 2/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.55 |
| ▸ | CASP1 | P29466 | 11/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.49 |
| ▸ | CTSS | P25774 | 2/20 | 0.46 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28836239 | 1.00 | PPARA (0.57) | PPARAFOLH1CASP1PPARGALDH1A1 | |
| SCHEMBL24448342 | 0.90 | PPARA (0.51) | PPARAFOLH1CASP1PPARGCTSS | |
| SCHEMBL8202407 | 0.90 | PPARA (0.51) | PPARAFOLH1CASP1PPARGCTSS | |
| SCHEMBL28595041 | 0.86 | PPARA (0.64) | PPARAFOLH1CASP1PPARGALDH1A1 | |
| SCHEMBL1171673 | 0.86 | PPARA (0.64) | PPARAFOLH1CASP1PPARGALDH1A1 | |
| SCHEMBL1024175 | 0.86 | PPARA (0.64) | PPARAFOLH1CASP1PPARGALDH1A1 | |
| SCHEMBL27474758 | 0.86 | CASP1 (0.49) | PPARAFOLH1CASP1ALDH1A1CTSS | |
| SCHEMBL27490859 | 0.85 | CASP1 (0.48) | CASP1ALDH1A1CTSSCTSLCTSK | |
| SCHEMBL10884777 | 0.84 | ALDH1A1 (0.63) | CASP1ALDH1A1MME | |
| SCHEMBL2977396 | 0.84 | ALDH1A1 (0.63) | CASP1ALDH1A1MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115053184-B | Composition for forming EUV resist underlayer film | 日产化学株式会社 | 2024-12-06 | — | — | CN | disclosed |
| CN-115053184-A | Composition for forming EUV resist underlayer film | 日产化学株式会社 | 2022-09-13 | — | — | CN | disclosed |
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
| US-20090275727-A1 | Peptide turn mimetics | MIMETICA PTY LIMITED (AU) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275727-A1 | Peptide turn mimetics | IAPP, GLP1R, VIP | PPARA 4156/4885FOLH1 364/4885CASP1 1995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.